Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34540323)
Watch
English
Bisphosphonates in bone diseases other than osteoporosis.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11858352
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11858352%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Bisphosphonates in bone diseases other than osteoporosis
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11858352
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11858352%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
main subject
osteoporosis
0 references
author
Johann Beaudreuil
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11858352
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11858352%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
author name string
Philippe Orcel
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11858352
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11858352%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
publication date
1 January 2002
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11858352
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11858352%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
published in
Joint Bone Spine
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11858352
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11858352%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
volume
69
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11858352
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11858352%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
issue
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11858352
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11858352%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
page(s)
19-27
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11858352
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11858352%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
cites work
Alendronate for the Treatment of Osteoporosis in Men
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of bone diseases with bisphosphonates, excluding osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bisphosphonates in the treatment of malignant bone disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of daily etidronate on the osteolysis of multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double-blind placebo-controlled trial. Danish-Swedish co-operative study group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clodronate decreases the frequency of skeletal metastases in women with breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reduction in new metastases in breast cancer with adjuvant clodronate treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The management of Paget's disease of bone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risedronate in the treatment of Paget's disease of bone: an open label, multicenter study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paget's disease: acquired resistance to one aminobisphosphonate with retained response to another.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pamidronate in the treatment of Paget's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term effects of intravenous pamidronate in fibrous dysplasia of bone.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term aminobisphosphonate treatment of fibrous dysplasia: spectacular increase in bone density
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cyclic administration of pamidronate in children with severe osteogenesis imperfecta
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of severe, recalcitrant reflex sympathetic dystrophy: assessment of efficacy and safety of the second generation bisphosphonate pamidronate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bisphosphonate therapy of reflex sympathetic dystrophy syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Analgesic effect of intravenous pamidronate on chronic back pain due to osteoporotic vertebral fractures
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased bone mass with pamidronate treatment in rheumatoid arthritis. Results of a three-year randomized, double-blind trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Short-term effects of pamidronate in patients with Gaucher's disease and severe skeletal involvement
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diphosphonates for periarticular ossification
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1297-319X%2801%2900336-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1297-319X(01)00336-0
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11858352
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11858352%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
PubMed publication ID
11858352
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11858352
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11858352%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit